Impacts of a Statewide Prescription Drug Monitoring Program—Healthcare Practitioner Perspectives

Emma Tay, Meredith Makeham, Tracey‐Lea Laba, Melissa Baysari

Open source

DOI: 10.1002/prp2.70326
Published: 2026-09-18
Container: Pharmacology Research & Perspectives
Publisher: Wiley
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/prp2.70326,
  title = {Impacts of a Statewide Prescription Drug Monitoring Program—Healthcare Practitioner Perspectives},
  author = {Emma Tay and Meredith Makeham and Tracey‐Lea Laba and Melissa Baysari},
  year = {2026},
  journal = {Pharmacology Research \&amp; Perspectives},
  doi = {10.1002/prp2.70326},
  url = {https://doi.org/10.1002/prp2.70326}
}

RIS

TY  - JOUR
TI  - Impacts of a Statewide Prescription Drug Monitoring Program—Healthcare Practitioner Perspectives
AU  - Emma Tay
AU  - Meredith Makeham
AU  - Tracey‐Lea Laba
AU  - Melissa Baysari
PY  - 2026
JO  - Pharmacology Research &amp; Perspectives
DO  - 10.1002/prp2.70326
UR  - https://doi.org/10.1002/prp2.70326
ER  -

APA

Tay, E., Makeham, M., Laba, T., & Baysari, M. (2026). Impacts of a Statewide Prescription Drug Monitoring Program—Healthcare Practitioner Perspectives. Pharmacology Research & Perspectives. https://doi.org/10.1002/prp2.70326

Source records

crossref · retrieved 2026-09-24T19:43:04.221Z